The Food and Drug Board Authority (FDA) has alerted the public and health workers on the circulation of counterfeit antimalarial drug- Combiart Tablets (Artemether/ Lumefantrine) on the Ghanaian market. According to the FDA, it market surveillance activity samples of the counterfeit antimalarial from the Northern Region revealed that the drug did not contain any of the two active pharmaceutical ingredients stated on the label.